Physician and clinician adoption risk
The systems require clinical acceptance and procedural use to generate recurring revenue.
- Scope
- TULSA-PRO and Sonalleve commercialization
- Materiality
- high
Profound Medical Corp.
Profound Medical Corp. develops and commercializes MRI-guided, incision-free therapies for treating diseased tissue, centered on its TULSA-PRO and Sonalleve systems. The company is organized around a holding-company structure with operating subsidiaries and serves hospitals, clinics, and physician-led treatment centers in North America, Europe, and Asia.
−254,0 %
70,8 %
−264,4 %
+50,7 %
12.52
11.17
| % | |
|---|---|
| TULSA-PRO systems | 45% MRI-guided prostate therapy systems used for incision-free ablation procedures. |
| Sonalleve systems | 20% MRI-guided ablation systems marketed mainly outside North America. |
| Disposable devices | 20% One-time-use devices consumed per patient treated on installed systems. |
| Clinical and service revenue | 15% Genius services, procedure support, warranties, and maintenance services. |
Profound sells to hospitals, clinics, and other end-users that perform MRI-guided procedures, often through a mix of...
- Hospitals and clinicsprimary
Buy TULSA-PRO or Sonalleve systems and recurring consumables to perform MRI-guided procedures.
- Physicians and cliniciansprimary
Influence product adoption, procedure protocols, and ongoing clinical utilization.
- Distributorssecondary
Purchase and resell products in markets where Profound lacks direct sales coverage.
- MRI scanner ecosystem partnerssecondary
Philips, Siemens, and GE-related channels support lead generation and distribution.
Profound has generated revenue in the United States, Europe, and Asia, with the United States using a hybrid recurring...
- •United States is a core market for TULSA-PRO commercialization
- •Europe and Asia are important markets for system sales and consumables
- •Outside North America, Sonalleve is marketed primarily in Europe and Asia
- •Direct sales are supplemented by distributors where no local presence exists
- •Compatibility with Philips, Siemens, and GE MRI scanners shapes market access
Profound’s strategy is to expand adoption of TULSA-PRO and Sonalleve by building direct sales capability, supporting...
01
Expand TULSA-PRO adoptionshort-term
Installed-base utilization and procedure volume drive recurring device and service revenue.
02
Strengthen reimbursement evidencemedium-term
Coverage by government and private payors supports broader clinical adoption.
03
Broaden commercial reach through partnershipsshort-term
MRI ecosystem partners help generate leads and reduce commercialization friction.
04
Expand product compatibility and indicationsmedium-term
Wider MRI compatibility and new applications can enlarge the addressable market.
Profound depends on physician adoption, reimbursement support, and continued regulatory clearance for its MRI-guided...
Reimbursement and coverage risk
Coverage by government and private payors affects market uptake and procedure economics.
- Scope
- Clinical evidence and reimbursement efforts
- Materiality
- high
Single-source supplier dependence
Some components are sourced from a single supplier, creating supply and quality risk.
- Scope
- TULSA-PRO and Sonalleve components
- Materiality
- high
MRI compatibility and partner dependence
Commercial success depends on compatibility with select MRI scanners and partner promotion.
- Scope
- Philips, Siemens, and GE ecosystems
- Materiality
- high
Distributor credit and collection risk
Open-credit sales and international distributor terms can delay or impair cash collection.
- Scope
- International distributor channels
- Materiality
- medium
Revenue recognition by product and service type
Affects quarterly revenue mix and comparability
Expected credit loss allowance
Affects receivables and bad debt expense
Quarterly mix volatility
Affects reported growth and margin patterns
Share-based compensation
Affects SG&A and R&D expense levels
Hyperfine, Inc.
HYPR · Electromedical & Electrotherapeutic Apparatus
Sensus Healthcare, Inc.
SRTS · Surgical & Medical Instruments & Apparatus
FONAR CORP
Electromedical & Electrotherapeutic Apparatus
FONAR Corp designs, manufactures, sells, and services MRI scanners, with a distinctive focus on its Upright® MRI system that can image patients in weight-bearing positions.
Profusa, Inc.
PFSA · Surgical & Medical Instruments & Apparatus
ProPhase Labs, Inc.
PRPH · Pharmaceutical Preparations
IRADIMED CORP
IRMD · Surgical & Medical Instruments & Apparatus
IRADIMED Corp designs and sells MRI-compatible medical devices used inside scanner rooms, centered on infusion pumps, patient vital signs monitoring systems, and related disposables and service.
: 29/04/2026